10 varieties of 9 pharmaceutical companies have been reviewed!

According to relevant national policies, drug varieties that have passed the consistency evaluation will receive greater support in the fields of medical insurance payment and procurement by medical institutions
.
According to the author's incomplete statistics, since March, at least 10 varieties have passed the consistency evaluation, involving 9 pharmaceutical companies including Yabao Pharmaceuticals, China Resources Shuanghe, Shanghai Pharmaceuticals, and China Pharmaceuticals, of which 2 varieties of Shanghai Pharmaceuticals have passed the consistency evaluation.
comment
.
On March 15, Baiyunshan announced that its subsidiary, Baiyunshan Pharmaceutical General Plant, Amoxicillin Granules received the "Approval Notice for Supplementary Drug Application" issued by NMPA, and that Amoxicillin Granules had passed the consistency of quality and efficacy of generic drugs.
evaluation
.
The drug is suitable for a variety of infections caused by susceptible bacteria (strains that do not produce β-lactamase)
.
On March 14, Joincare announced that Livzon Group, a controlling subsidiary of the company, recently received the "Approval for Supplementary Drug Application" issued by NMPA.
The clarithromycin tablets produced by Livzon Pharmaceutical Factory passed the quality and Efficacy consistency evaluation
.
The drug belongs to the category B of the National Medical Insurance Catalogue and is suitable for the treatment of infections caused by pathogenic bacteria sensitive to clarithromycin
.
On March 13, Warner Pharmaceuticals issued an announcement.
Recently, the company received the "Approval Notice of Drug Supplementary Application" for Mycophenolate Mofetil Capsules approved and issued by the State Drug Administration.
The drug has passed the quality and efficacy of generic drugs.
Consistency evaluation
.
The announcement stated that Mycophenolate Mofetil Capsules, administered simultaneously with corticosteroids and cyclosporine or tacrolimus, are suitable for the treatment of patients undergoing allogeneic kidney transplantation and liver transplantation to prevent organ rejection, and are also suitable for III- Induction and maintenance therapy in adult patients with type V lupus nephritis
.
On March 12, Changjiang Health announced that the company had recently received a notice from its wholly-owned subsidiary Hailing Pharmaceuticals that Hailing Pharmaceuticals had received the “Supplementary Application for Drugs” approved and issued by the State Drug Administration for Cefminox Sodium for Injection.
Approval Notice" to approve the drug to pass the consistency evaluation of generic drug quality and efficacy
.
The announcement shows that the product is mainly used to treat sepsis, tonsillitis, acute bronchitis, pneumonia caused by cefminox-sensitive Streptococcus, Streptococcus pneumoniae, Escherichia coli, Klebsiella, Proteus, etc.
, chronic respiratory disease secondary infection and other diseases
.
On March 11, Tianyao Co.
, Ltd.
issued an announcement saying that its subsidiary Jinyao Pharmaceuticals Metahydroxylamine Bitartrate Injection received the "Approval Notice for Drug Supplementary Application" approved and issued by NMPA, which approved the drug to pass the quality and efficacy of generic drugs.
Sexual evaluation
.
It is reported that this product is suitable for the prevention and treatment of acute hypotension during spinal anesthesia; hypotension caused by bleeding, drug allergy, surgical complications, and brain trauma or brain tumor combined with shock; this product can be used for adjuvant symptomatic treatment ; Can also be used for hypotension due to cardiogenic shock or sepsis
.
On March 9, Sinopharm issued an announcement.
Recently, Tianfang Co.
, Ltd.
, a wholly-owned subsidiary of the company, received a "Approval Notice for Supplementary Drug Application" for risedronate sodium tablets approved and issued by the State Food and Drug Administration.
Consistency evaluation of pharmaceutical quality and efficacy
.
It is reported that risedronate sodium tablets are suitable for the treatment and prevention of osteoporosis in postmenopausal women
.
On March 8, Fangsheng Pharmaceutical announced that the company received the "Approval Notice for Supplementary Drug Application" issued by the State Drug Administration for Cefixime Tablets, confirming that the drug has passed the quality and efficacy consistency evaluation of generic drugs.

.
As of the announcement date, a total of 3 pharmaceutical companies, including Fangsheng Pharmaceutical, have reviewed the product
.
On March 4, Yabao Pharmaceutical issued an announcement stating that the company recently received the "Approval Notice of Drug Supplementary Application" for Methylcobalamin Injection approved and issued by NMPA, and approved the drug to pass the consistency evaluation of generic drugs
.
The drug is mainly used for the treatment of peripheral neuropathy and macrocytic anemia caused by lack of vitamin B12
.
Also on the 4th, China Resources Shuanghe announced that its wholly-owned subsidiary Shuanghe Limin had recently received the "Approval Notice for Drug Supplementary Application" for Ambroxol Hydrochloride Injection issued by NMPA.
Efficacy consistency evaluation
.
This product is suitable for acute and chronic lung diseases with abnormal sputum secretion and poor expectoration function
.
On March 3, Shanghai Pharmaceuticals announced that recently, Shandong Xinyi, a subsidiary of Shanghai Pharmaceuticals, received the "Approval Notice for Supplementary Drug Application" issued by the State Drug Administration for Flunarizine Hydrochloride Capsules.
Generic Drug Consistency Evaluation
.
It is reported that the drug is mainly used for the preventive treatment of typical (with aura) or atypical (without aura) migraine
.
As of the announcement date, the company has invested approximately RMB 6.
9658 million in research and development for the consistency evaluation of the drug
.
On March 11, Shanghai Pharmaceuticals also announced that Shanghai Shanghai Pharmaceutical Xinyi Pharmaceutical Factory, a wholly-owned subsidiary of the company, received the "Approval Notice for Supplementary Drug Application" issued by the State Drug Administration for methotrexate tablets.
Generic drug consistency evaluation
.
According to the announcement, methotrexate tablets are mainly used for various types of acute leukemia
.
As of the announcement date, the company has invested approximately RMB 7.
64 million in research and development expenses for the consistency evaluation of the drug
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.